Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.62%
#2 Ontology Gas Ontology Gas +182.29%
#3 PulseChain PulseChain +57.88%
#4 Ontology Ontology +40.20%
#5 ConstitutionDAO ConstitutionDAO +36.86%
#6 Osmosis Osmosis +36.34%
#7 BOOK OF MEME BOOK OF MEME +31.61%
#8 Collect on Fanable Collect on Fanable +26.31%
#9 Neiro Neiro +25.71%
#10 Pump.fun Pump.fun +24.19%
Coin of the day
Pleasing Gold Pleasing Gold
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
Pozycja w akcjach #25838
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
Cena akcji
$0.74834668
Kapitalizacja rynkowa
$45.86M
Zmiana (1 dzień)
-0.15%
Zmiana (1 rok)
-6.28%
Kraj
SE
Handel Mendus AB (publ) (IMMU)

Kategoria

Healthcare
Historia stopy dywidendy dla Mendus AB (publ) (IMMU)
Stopa dywidendy (TTM) dla Mendus AB (publ) (symbol akcji: IMMU) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Mendus AB (publ) (IMMU) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US